Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

𝐍𝐞𝐰 𝐒𝐡𝐨𝐰 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐦𝐞𝐧𝐭: Today BiotechTV is excited to announce our newest regular show - Off-Target Effects with Matt Gline. Matt will share his perspective on news, and interview other biotech leaders. Visit the show's dedicated page:

BiotechTV

11,833 subscribers

37,153 views • 1 year ago •via X (Twitter)

Education Science & Technology News & Politics

Anya Rossi• Live Now

Private livecam show

4 Comments

Pavan Cheruvu1 year ago

@gline What a cool idea. I will definitely tune in, @gline!

The Information1 year ago

The best new tech and business podcasts of 2024. Plus, podcasting's $400 million man.

Brent Smith eXp Realty Naples Real Estate1 year ago

@gline Nice! Can't wait. Have your first interview with Sandy Mcrae of Sangamo Therapeutics. @SGMO @SangamoTx @gline

Bio Explorer1 year ago

@gline Looks super interesting. Look forward to it!

Related Videos

𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: Tune in tomorrow morning for a new episode of Off-Target Effects with Roivant Sciences CEO Matt Gline. Matt's next guest needs no introduction and is one of the most experienced investors in biotech, Perceptive Advisors' CEO and Portfolio Manager Joe Edelman!

𝐓𝐨𝐦𝐨𝐫𝐫𝐨𝐰: Tune in tomorrow morning for a new episode of Off-Target Effects with Roivant Sciences CEO Matt Gline. Matt's next guest needs no introduction and is one of the most experienced investors in biotech, Perceptive Advisors' CEO and Portfolio Manager Joe Edelman!

BiotechTV

20,583 views • 2 months ago

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: Perceptive Advisors' Joe Edelman discusses with Roivant Sciences CEO Matt Gline how biotech investing has changed over his extensive career, and his philosophy on running an investment firm. Watch the full episode:

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: Perceptive Advisors' Joe Edelman discusses with Roivant Sciences CEO Matt Gline how biotech investing has changed over his extensive career, and his philosophy on running an investment firm. Watch the full episode:

BiotechTV

17,172 views • 2 months ago

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: Matt Gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector. Full video:

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: Matt Gline speaks with Avoro Capital's Behzad Aghazadeh about the hot button issues that have been striking the biotech sector. Full video:

BiotechTV

20,811 views • 1 year ago

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

BiotechTV

11,722 views • 4 months ago

New Program Announcement: BioVenture VoiCes with Chris Garabedian. Today we welcome a regular new program on BiotechTV. Chris Garabedian will host the top venture investors in biotech to get their insights on the sector. Watch here in the future:

New Program Announcement: BioVenture VoiCes with Chris Garabedian. Today we welcome a regular new program on BiotechTV. Chris Garabedian will host the top venture investors in biotech to get their insights on the sector. Watch here in the future:

BiotechTV

16,073 views • 2 years ago

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: John Maraganore 🇺🇸🇬🇷🇺🇦 has been a champion of innovation throughout his career. He and Matt Gline discuss the road to success at Alnylam Pharmaceuticals, today's environment, and keeping the U.S. on top. Watch the episode:

𝐎𝐟𝐟-𝐓𝐚𝐫𝐠𝐞𝐭 𝐄𝐟𝐟𝐞𝐜𝐭𝐬: John Maraganore 🇺🇸🇬🇷🇺🇦 has been a champion of innovation throughout his career. He and Matt Gline discuss the road to success at Alnylam Pharmaceuticals, today's environment, and keeping the U.S. on top. Watch the episode:

BiotechTV

18,640 views • 4 months ago

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Meet some of the incredible Female Biotech CEO leaders of the Biotech CEO Sisterhood!

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Meet some of the incredible Female Biotech CEO leaders of the Biotech CEO Sisterhood!

BiotechTV

12,276 views • 7 months ago

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:

𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:

BiotechTV

13,777 views • 9 months ago

Shoutout to The Today Show for sharing our interview with Ben Affleck and Matt Damon!

Shoutout to The Today Show for sharing our interview with Ben Affleck and Matt Damon!

Project Big Screen

270,882 views • 7 months ago

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy. See the whole interview here:

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy. See the whole interview here:

BiotechTV

16,344 views • 7 months ago

𝐔.𝐒. 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐒𝐮𝐦𝐦𝐢𝐭: Alexis Borisy shares his take on one of today's biggest debates in biotech, the impact of China on the U.S. biotech sector.

𝐔.𝐒. 𝐒𝐜𝐢𝐞𝐧𝐜𝐞 𝐒𝐮𝐦𝐦𝐢𝐭: Alexis Borisy shares his take on one of today's biggest debates in biotech, the impact of China on the U.S. biotech sector.

BiotechTV

12,038 views • 1 month ago

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: Mizuho Senior Analyst Graig Suvannavejh shares his take on biotech and companies he covers that are in the news with key catalysts. $TERN $CRVS $INSM $CRBP $AXSM $NMRA $EYPT $AMLX Full video:

BiotechTV

17,128 views • 8 months ago

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:

𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:

BiotechTV

11,800 views • 1 year ago

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:

BiotechTV

25,829 views • 7 months ago

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲𝐬: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:

𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐓𝐡𝐮𝐫𝐬𝐝𝐚𝐲𝐬: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:

BiotechTV

29,397 views • 6 months ago

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Kicking off our coverage of biotech's biggest week. Meet the BiotechTV team who will be blanketing Union Square to cover it all. Brad Loncar Amy Brown Ryan Flinn Chloe Kirk

𝐒𝐅 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐖𝐞𝐞𝐤: Kicking off our coverage of biotech's biggest week. Meet the BiotechTV team who will be blanketing Union Square to cover it all. Brad Loncar Amy Brown Ryan Flinn Chloe Kirk

BiotechTV

13,516 views • 7 months ago

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:

From NYSE: Gameto CEO Dina Radenkovic / Turner talks about running a women's health biotech, the development of Fertilo, work on menopause, and more. Full video:

BiotechTV

14,405 views • 1 year ago

Company News: Intellia Therapeutics's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy. $NTLA Full video:

Company News: Intellia Therapeutics's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy. $NTLA Full video:

BiotechTV

21,950 views • 2 years ago